Acute myeloid leukemia (AML) evolves over time based on how the disease responds to treatment. AML remission, relapse, and refractory disease are key concepts…
Blood cancer
Blood cancer is a broad term encompassing diseases in which blood cells grow too much or develop abnormally. Typically, blood cancers are classified into three main categories – leukemia, lymphoma, and myeloma – but they can be further divided into dozens of specific types, each with unique features.
A wide range of therapies are available for treating blood cancer, from chemotherapy and targeted therapy to radiation, stem cell transplant, and surgery. When devising a suitable treatment plan for blood cancer, healthcare providers take into account various factors, such as age, overall health, the specific type of blood cancer, and potential treatment side effects.
Latest news
There is no standardized staging system for acute myeloid leukemia (AML). Instead of AML stages, the blood cancer is classified by factors such…
The prognosis of acute myeloid leukemia (AML) is different for each individual and can change over time depending on how the blood cancer evolves…
Acute myeloid leukemia (AML) is a blood cancer marked by the out-of-control growth of immature blood cells known as blast cells, or simply,…
Acute myeloid leukemia (AML) is a blood cancer marked by the out-of-control growth of immature blood cells known as blast cells or blasts.
Discussion
ACUTE MYELOID LEUKEMIA
FDA green lights first-in-human study of infusion leukemia treatment
The U.S. Food and Drug Administration (FDA) has given Orum Therapeutics the go-ahead to launch its first clinical trial testing ORM-1153, an experimental treatment…


